GNRH1 and polycystic ovary syndrome: In line with this information, NUCB2/nesfatin-1 has been investigated in patients with PCOS undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) with a gonadotropin-releasing hormone (GnRH) antagonist protocol.